https://sputnikglobe.com/20200907/russias-vector-to-finish-clinical-trials-of-covid-19-vaccine-on-30-september-1080387028.html
Russia's Vector to Finish Clinical Trials of COVID-19 Vaccine on 30 September
Russia's Vector to Finish Clinical Trials of COVID-19 Vaccine on 30 September
Sputnik International
MOSCOW (Sputnik) - Russia's State Research Centre of Virology and Biotechnology Vector will complete the clinical trials of its vaccine against COVID-19 on 30... 07.09.2020, Sputnik International
2020-09-07T08:13+0000
2020-09-07T08:13+0000
2020-09-07T08:13+0000
https://cdn1.img.sputnikglobe.com/img/07e4/08/15/1080234774_0:222:3072:1960_1920x0_80_0_0_a5dbd05d94bd777e95da49069f7946c5.jpg
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2020
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, russia, coronavirus, vaccine
newsfeed, russia, coronavirus, vaccine
Russia's Vector to Finish Clinical Trials of COVID-19 Vaccine on 30 September
MOSCOW (Sputnik) - Russia's State Research Centre of Virology and Biotechnology Vector will complete the clinical trials of its vaccine against COVID-19 on 30 September, Anna Popova, the head of the Rospotrebnadzor public health watchdog, said on Monday.
"Our colleagues are focusing on one vaccine, the peptide vaccine, its clinical trials are now being completed. 30 September is the final date", Popova said at the All-Russian Congress on Infectious Diseases.
Clinical trials of Russia’s second coronavirus vaccine is set to be concluded in late September, Deputy Prime Minister Tatyana Golikova said in August, adding that no complications among the volunteers have been registered. If successful, the vaccine will carry the name EpiVacCorona.
7 September 2020, 05:00 GMT
The press service of the Russian consumer health watchdog previously said that all volunteers for the Stage 1 of clinical trials for the COVID-19 vaccine of Russian research center Vektor have developed antibodies.
Earlier in August, Russian President Vladimir Putin announced the registration of the world’s first vaccine against the virus that causes COVID-19, which was developed by the Russian Gamaleya Research Institute.
